Pfizer CEO Says Vaccine Could Be Available by the End of the Year
CEO of Pfizer Albert Bourla said in an interview that “it is likely” that the US will be able to provide the Covid-19 vaccine before the end of 2020. He said he is “quite comfortable” that the vaccine Pfizer and BioNTech are working on together is safe and will be avail able for Americans pending the approval from the FDA.
This vaccine candidate is a forerunner in the race for the Covid-19 vaccine with other’s we have mentioned at this blog, Moderna and AstraZeneca. Bourla believes they will have their research efficacy data by the end of October. He said, “Of course that doesn’t mean that it works; that means that we’ll know if it works.” However, positive results could mean that the vaccine candidate gets approved, he said.
Pfizer and BioNTech are set to expand their testing by another 14,000 participants up from the original 30,000 patients they had for clinical trials. They will be expanding the age range down to 16 years of age, and trying to add more people of color into their testing. Currently participates are 60% white and 40% people of color.
With the pressure of politics on Pfizer and many other vaccine hopeful companies, a pledge has been made to only submit the applications for the FDA vaccine approval when the candidates have been shown to be safe and effective. This has come on the heels of President Trump pushing developers to cut corners to meet the November 3 election deadline.
President Trump has said that a vaccine could be authorized before the election despite what other top health officials have said regarding the timeline of viable vaccine candidates. The NIH director Francis Collins believes the target should and be closer to the end of the year. Scott Gottlieb, a member of Pfizer’s board of directors said, ““I don’t think we’re going to see an authorization before the election,” and that he expects most Americans to be vaccinated in 2021 or even later.
Be sure to check back at the ABN Blog regularly for Updates to this and other vaccine related information.